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Abstract
Bovine respiratory disease complex (BRDC) is an important cause of mortality and morbid-
ity in cattle; costing the dairy and beef industries millions of dollars annually, despite the use
of vaccines and antibiotics. BRDC is caused by one or more of several viruses (bovine
respiratory syncytial virus, bovine herpes type 1 also known as infectious bovine rhinotra-
cheitis, and bovine viral diarrhea virus), which predispose animals to infection with one or
more bacteria. These include: Pasteurella multocida,Mannheimia haemolytica,Myco-
plasma bovis, and Histophilus somni. Some cattle appear to be more resistant to BRDC
than others. We hypothesize that appropriate immune responses to these pathogens are
subject to genetic control. To determine which genes are involved in the immune response
to each of these pathogens it was first necessary to experimentally induce infection sepa-
rately with each pathogen to document clinical and pathological responses in animals from
which tissues were harvested for subsequent RNA sequencing. Herein these infections and
animal responses are described.
Introduction
The bovine respiratory disease complex (BRDC) is a multi-agent disease of cattle often referred
to as “shipping fever.” It has been and continues to be one of the largest causes of morbidity
and mortality of dairy calves and feedlot cattle [1]. Despite rigorous research and development
of vaccines containing some or all of the major BRDC pathogens, the disease remains a major
cause of financial loss to the cattle industry. BRDC is associated with several bacterial patho-
gens, of which the major ones are: Pasteurella multocida,Mannheimia haemolytica,
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Mycoplasma bovis, andHistophilus somni. Disease occurs when a viral pathogen: Bovine respi-
ratory syncytial virus (BRSV), Bovine Herpes virus type 1 (infectious bovine rhinotracheitis,
IBR), Bovine parainfluenza 3 virus, or Bovine viral diarrhea virus (BVDV) infects the host and
weakens resistance to the bacterial pathogen, which is often already present in the upper respi-
ratory tract. Stress is another factor that facilitates the development of BRDC. The term “ship-
ping fever” is often used because the stress of shipping cattle to a feed yard facilitates the
suppression of immune responses at a time when animals are mixed together in close quarters
allowing viral transmission [2].
Each of the BRD pathogens has unique features that contribute to the ability of the pathogen
to cause disease and to resist host defenses. These are summarized in Table 1 for the pathogens
used in the infection studies described herein.
The aim of this study was to develop and characterize experimental infection protocols for
each of the BRC pathogens. We hypothesize that each of these organisms elicits a particular
immune response from the host and that the most appropriate response can be identified by
evaluation of gene usage in single pathogen infections. To determine which genes are involved
in a protective immune response it is necessary to experimentally induce each infection sepa-
rately and to monitor clinical and pathological responses in infected animals using these infec-
tion protocols. Necropsy tissues can be harvested to serve as a source of RNA for sequence
analysis and cells can be obtained for analysis of the immune response [3].
Table 1. Characteristic Features of Major BRD Pathogens.
Viral Pathogens
Pathogen Characteristics Mechanisms of Pathogenesis Effect on Host Response
Bovine
Respiratory
Syncytial Virus
Negative strand RNA
virus, Paramyxoviridae
Entry through respiratory mucosa; infects
bronchial epithelium, causes syncytial cell
formation, bronchiolitis. Fever, cough, increased
respiratory rate, depression
Immune modulation favoring T helper type 2
cytokines, which depresses cytotoxic T cell
induction [15]
Bovine Herpes
Virus 1 (IBR)
DNA virus, Herpesviridae,
alphavirinae
Entry through respiratory mucosa; causes
epithelial cell apoptosis. Fever, rhinotracheitis,
cough, conjunctivitis, oral ulcers; reproductive tract
infection with abortion5
Evades host defenses: depresses Interferon 1
responses, latency, suppresses CMI by interfering
with TAP peptide MHC 1, interference with
chemokine function [16,17]
Bovine Viral
Diarrhea Virus
Positive strand RNA virus,
Flaviviridae, two biotypes
1 and 2
Spread in secretions; causes multiple system
disease (abortion, persistent infection.
Causes immunosuppression, targeting and killing
lymphoid tissue in Peyer’s Patches [12,18]
Bacterial Pathogens
Pasteurella
multocida
Gram negative
coccobacillus, family
Pasteurellaceae
Part of normal microbiota in upper respiratory
tract; stress or viral infections allow it to infect lung
and cause bronchopneumonia
Multiple virulence factors: anti-phagocytic capsule,
LPS, protein toxin[11,13,19]
Mannheimnia
hemolytica
Gram negative
coccobacillus, family
Pasteurellaceae
Upper respiratory tract commensal; opportunistic
pathogen causing bronchopneumonia
Multiple virulence factors: adhesin, capsular poly-
saccharide, leukotoxin, LPS, transferrin binding
protein [20,21]
Mycoplasma
bovis
Wall-less bacterium of
class Mollicutes
Causes mastitis, arthritis, otitis media, pneumonia,
fever, cough, anorexia, nasal discharge;
synergistic with other BRD pathogens, forms
bioﬁlms to facilitate persistence
Variable surface membrane lipoprotein antigens,
adhesins, immune modulation (to Th2), inhibits
neutrophil respiratory burst [22,23]
Histophilus somni Gran negative
coccobacillus,
Pasteurellaceae
Upper respiratory tract, reproductive tract
commensal; Diseases: thrombotic
meningoencephalitis (TME), respiratory disease,
myocarditis, polysynovitis, otitis media, mastitis,
and reproductive tract diseases.
Virulence factors: LPS, LOS, apoptosis of
endothelial cells,Immunoglobulin binding protein
[24].
doi:10.1371/journal.pone.0142479.t001
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Methods
Animals and husbandry
Angus-sired crossbred steers were obtained from the Sierra Field Station of the University of
California Davis (UCD) located in Brown’s Valley, CA where they had been raised since birth.
This study was carried out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of Health. The protocol
(#16424) was approved by the University of California, Davis, Institutional Animal Care and
Use Committee. Blood was obtained and titers were determined against each viral pathogen,
and those seronegative or with lowest titers were chosen for use in the experiment. Six to eight
month old steers were shipped to UCD where they were housed in pens of 4 each at the Uni-
versity’s Animal Science cattle facility. All facilities were thoroughly disinfected between patho-
gen challenges. The steers were fed a starter diet consisting of 65% concentrate and water ad
libitum. A total of six steers were used for each pathogen challenge (2 in the pilot study and 4
in the optimal study) and a total of three steers were used for viral controls and an additional
three for the bacterial challenge controls. The Angus-Hereford cross steers were used partially
due to availability and more importantly to have a broader genetic composition included in the
resultant tissue bank than would result from using purebred cattle in line with the ultimate
goal of creating an RNA tissue source that is broadly representative of cattle. A power calcula-
tion performed to determine the appropriate number of animals to use for a 95% confidence
interval was performed using our previous data on experimental BRSV infection. We used clin-
ical scores in controls versus experimentally infected calves for the power analysis.
Experiment Design
An initial pilot study was carried out in 2011 to determine the appropriate time course for each
experimental infection so that tissue samples could be harvested at the time of maximal clinical
signs (see Pilot Study results). The following year a larger challenge study utilizing additional
animals per treatment for increased statistical significance was carried out using optimal condi-
tions as informed by the pilot study. For some pathogens conditions and necropsy timing
remained unchanged between the pilot and the challenge trial (IBR, BRSV). Whereas for the
other pathogens different pathogen isolates and/or timing for infection was implemented
based on the results from the pilot trial (Table 2).Histophilus somni was included in the pilot
study, but did not achieve sufficient clinical signs or re-isolation of the bacterium to provide
useful data. Animals available for the optimal study were inadvertently vaccinated for H.
somni, making them unacceptable for use. Thus, H. somni data is not included herein. Each
year infections were performed sequentially in groups of steers for each pathogen after a rest
period to clean and disinfect facilities.
Bacterial agents; methods of infection
The numbers of animals infected, source and dose of the virus, bacteria and mycoplasma
strains, used for infection in the pilot (2011) and challenge (2012) studies are listed in Table 2.
The total number of animals infected with each pathogen was six. A power calculation was per-
formed for BRSV (the pathogen with which we had the greatest experience and data) and an
n = 6 was determined to be sufficient for a 95% confidence interval. Data from pilot and opti-
mal studies were combined to achieve an “n” of 6.
Mannheimia haemolytica was grown on blood heart infusion (BHI) agar with 5% sheep
blood in a 5% CO2 incubator at 37°C for 24 hours. A growth curve was determined and corre-
lated with optical density using isolated colonies grown at room temperature in BHI broth with
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shaking for 8 hours with sampling at 0–9 hours. Plate counts were performed to determine log
phase growth. The growth curve was repeated 3 times to assure reproducibility, with 1 × 109
CFU/ml corresponding to an OD650 of 0.809 after 7 hours of growth. Inoculum was prepared
by growing the bacteria for 7 hours, concentrated by centrifugation followed by washing in
cold phosphate buffered saline solution (PBS). Inoculum was prepared immediately prior to
infection and held on wet ice until administered. In the optimized experiment a dose of 40 ml
containing a total of 4.8 × 1011CFU/animal was administered to each steer intratracheally. The
inoculum was followed by 20 ml of sterile PBS and 60 ml of air to assure that the entire inocu-
lum was delivered into the respiratory tract.
Pasteurella multocida was grown on BHI as described forM. haemolytica and a growth
curve was determined and correlated with an optical density value for log phase growth. In the
optimized experiment each steer received by the intratracheal route 60 ml of bacteria for a total
dose of 1.13 X 1011 CFU/animal, followed by 40 ml of cold sterile PBS and 60 ml of air.
Mycoplasma bovis was grown from a frozen seed stock culture for two days in PPLO broth
in a 5% CO2 incubator at 37°C without shaking. A frozen stock was prepared and stored at
-80°C. A small aliquot was titered; plate counts were performed and the titer of the stock was
determined to be 3 × 1010 CFU/ml. On the day of infection, inoculum was prepared by diluting
the frozen stock to 1 × 109 CFU/ml. In the optimized experiment each steer received 7 × 1010
CFU by the intratracheal route followed by PBS and air as described above. Plate counts were
set up to confirm the actual dose per steer. Bacterial infection controls (n = 3) received a similar
inoculum of media (without bacteria) followed by PBS and air.
Viral agents; methods of infection
Strains and amounts of inocula for viral agents are reported in Table 2.
Table 2. Pathogens, doses, and animals.
Pathogen Source Dose Administered Animal IDs
Bovine Respiratory
Syncytial Virus
Dr. Laurel Gershwin—University of California,
Davis (CA-1)
1.6 × 105/ml ×8.5 ml/animal (both) 18, 33 (pilot1) 74, 77, 92, 116
(optimized1)
Bovine Herpes Virus– 2
(IBR)
CAHFS2 (ATCC, lot: VR188 LA strain) 1.0 × 107/ml × 8.5 ml/animal (both) 81, 138 (pilot) 59, 70, 76, 100
(optimized)
Bovine Viral Diarrhea
Virus
Dr. Chris Chase—South Dakota State University,
(890)
2.4 × 107/animal (pilot); 1.7 × 109/
animal (optimized)
82, 128 (pilot) 86, 98, 138, 139
(optimized)
Mannheimnia
haemolytica
CAHFS2 (pilot) Dr. Anthony Confer- Oklahoma
State University (optimized)(232)
9.6 × 107 CFU/animal (pilot) 4.8 x 1011
CFU/animal (optimized)
73, 75 (pilot) 88, 99, 113, 125
(optimized)
Pasteurella multocida CAHFS2 (pilot) Dr. Anthony Confer- Oklahoma
State University (optimized) (89020807N)
3.6 × 109 CFU/animal (pilot) 1.13 x
1011 CFU/animal (optimized)
111, 129 pilot (pilot) 75, 123,
127, 135 (optimized)
Mycoplasma bovis CAHFS2 (pilot) Dr. Ricardo Rosenbush- Iowa State
University (optimized) (428E)
3.5 ×1010 CFU/animal (pilot) 7.0 × 1010
CFU/animal (optimized)
43, 124 (pilot) 47B, 65,
1043,115 (optimized)
Virus control (media)4 NA Tissue culture media- same volume 25 (pilot); 58, 101 (optimized)
Bacterial control (PBS)4 NA PBS—same volume 70 (pilot); 71, 102 (optimized)
NA = not applicable.
1The pilot study was conducted in summer 2011. The optimized study was conducted in summer 2012.
2California Animal Health and Food Safety Laboratory, clinical isolate.
3Euthanized early, tissues not sampled.
4For each pathogen in the optimized study there were 4 control steers for clinical sign analysis (a total of 24 steers); these were not necropsied. Tissue
samples and pathology data was obtained from 3 additional numbered viral controls and 3 additional bacterial controls.
doi:10.1371/journal.pone.0142479.t002
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Bovine respiratory syncytial virus (BRSV) was removed from liquid nitrogen storage and
grown on bovine turbinate (BT) cells for 5 days in 5% CO2 at 37°C until cytopathic effect was
greater than 50%. Prior to infection of steers tissue culture media except for 10 ml was removed
from flasks and transferred to 50 ml conical tubes on ice. Cell sheets then were rapidly frozen
at– 80°C to release intracellular virus; media and cells were thawed and decanted into the 50 ml
tubes and centrifuged to remove cell debris. Supernatant was stored on ice for transport to the
animals. An aliquot was reserved and set up for TCID50 viral titer quantitation. The remainder
of the supernatant was administered to steers (8.5 ml/animal) using a DeVilbiss (Somerset,
PA) nebulizer/air compressor and face mask (Equine Aeromask, Trudell medical International
Animal Health).
Bovine herpes virus (IBR) was similarly inoculated onto BT cells and incubated until cyto-
pathic effect (CPE) was obvious at the time that virus was harvested and administered as
described for BRSV.
Previously frozen and titered BVDV strain 890 infection stock was grown on BT cells prior
to freezing at -80°C. The virus inoculum was defrosted and administered to the steers as
described for the other viral pathogens.
Viral control steers received an aerosol of spent but uninfected tissue culture media using a
similar nebulizer and facemask system that was designated for use only on the uninfected
controls.
Monitoring of clinical signs
Clinical scores were determined by daily evaluation as in the morning. Either a DVM or veteri-
nary student performed the examinations and provided daily assessment using a scoring sys-
tem based on a combination of the system described by [4] and one used by Gershwin [5], an
adaptation from Collie [6]. The point scoring systems used in the pilot and optimized studies
are described in Table 3. Using this system points were accumulated for each abnormal clinical
sign and the total number corresponded with severity of disease, such that high numbers were
associated with most severe disease. An expanded point system was used in the optimal study
(Table 3).
Samples
Deep pharyngeal swabs were obtained before infection and on the day of necropsy using a
guarded culture instrument with a sheathed polyester swab designed for uterine culture in
equine mares (Kalayjian Industries, Inc. Signal Hill, CA). The sheathed swab was inserted into
the ventral meatus of the nare and was advanced as far as possible before the internal swab was
briefly extended and then withdrawn back into the sheath prior to extraction from the nose.
These swabs were delivered to the California Animal Health and Food Safety Laboratory
(CAHFS) diagnostic facility, where culture media was inoculated.
Blood was obtained prior to selection of steers for the experiments and viral titers were per-
formed at CAHFS. Sero-negative steers were selected for viral infections. Animals used in the
bacterial infection challenges were not screened for antibodies in the pilot study. However, in
the optimized study, serum was sent to the laboratory of Dr. A. Confer (Oklahoma State Uni-
versity) forM. haemolytica and P.multocida titers which were performed by ELISA [7]. This
information was used to select steers with the lowest titers for the optimized study.
Necropsy
Steers were killed by captive bolt to the head, immediately hung, and exsanguinated by severing
the jugular veins. Lungs and other viscera were removed and examined by a board certified
Single Pathogen Challenge with Agents of the BRDC
PLOSONE | DOI:10.1371/journal.pone.0142479 November 16, 2015 5 / 23
veterinary pathologist. In the optimized study, the left lung was lavaged with a solution of
Hank’s balanced salt solution. Three 60 ml aliquots were sequentially instilled and withdrawn
from the lung using a foal sized stomach tube with internal polyethylene tube, equipped with a
3 way valve. Lavage fluid was stored on wet ice for transport to the laboratory after which the
cells were pelleted by centrifugation and frozen at -80°C for future RNA isolation. The super-
natant was stored at -20°C.
Table 3. Scoring system for Clinical Signs.
Study Parameter Evaluated Score Scale
Pilot Rectal temperature (T -39.5) × 100
Body Weight No point value
Nasal Discharge *0–3 × 10
Ocular Discharge 0–3 × 10
Ear position (droop) 0–3 ×10
Cough, induced and spontaneous,
evaluated separately
0–3 × 10
Respiratory Rate—breaths/minute × 1
Subcutaneous emphysema Yes or No
Mandibular lymph nodes Normal or enlarged
Lung sounds (left) 0–3 × 100
Lung sounds (right) 0–3 × 100
Tracheal sounds 0–3 × 10
Optimal Rectal temperature (T) T-39.5° X 40
Body weight No point value
Nasal discharge (each nostril scored
separately)
0–3 x 5 (serous), 10 (seromucoid), 15 (mucoid),
20 (mucopurulent)
Ocular discharge (each eye scored
separately)
0–3 x 5 (serous), 10 (seromucoid), 15 (mucoid),
20 (mucopurulent)
Ear position (droop) No point value
Spontaneous cough 0 (no), 40 (yes)
Induced cough 0 (no), 40 (yes)
Respiratory Rate (RR)–breaths/minute RR-40 x 1 =
Subcutaneous emphysema 0 (no), 100 (yes)
Mandibular lymph nodes 0 (normal), 50 (enlarged)
Lung sounds (harsh or quiet; each lung
scored separately)
0 (normal), 15 (mild/moderate), 30 (severe)
Tracheal sounds No point value
Crackles (each lung scored separately) 0 (no), 80 (yes)
Wheezes (each lung scored separately) 0 (n0), 60 (yes)
Respiratory character 0 (normal), 30 (shallow or deep)
Respiratory volume (each lung scored
separately)
0 (normal), 20 (mild/moderate reduction), 40
(severe reduction)
Apneustic breathing 0 (no), 30 (yes)
Mouth breathing 0 (no), 50 (yes)
Dyspnea 0 (no), 75 (yes)
Expiratory grunt 0 (no), 60 (yes)
Biphasic expiration 0 (no), 60 (yes)
*0–3 indicates magnitude, then x indicated weight factor
doi:10.1371/journal.pone.0142479.t003
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The respiratory tract was examined: larynx, trachea, bronchi, and lungs were examined and
lesions were recorded. Estimation of percent consolidation was made for each lung lobe. The
left lung was infused with 10% formalin for histopathological evaluation. From the right lung,
tissue samples were taken and immediately frozen in liquid nitrogen for RNA extraction and
eventual sequencing. Samples harvested included: tonsil, retropharyngeal lymph node, bron-
chial lymph node, spleen, liver, and both lesional and normal samples from the uninfused lung
lobe. At necropsy, swabs were taken from lung and bronchi and were submitted for bacterial
and mycoplasma culture. Immunohistochemistry was performed for BRSV, IBR, and BVDV.
Immunohistochemistry on Lung Sections
Immunohistochemistry was performed on lung sections for four pathogens: bovine herpes
virus -1 (BHV-1), BRSV, BVDV, andMycoplasma bovis. The slides were 3–5 micron sections
with an initial unmasking/decloaking step which was either 0.1% Protease type XIV (Sigma
P5147) for 15 minutes at 37C for both the BHV-1 and BVDV or the unmasking decloaking
step for the BRSV andMycoplasma bovis was 10X Decloaker citrate buffer (Biocare CB910M)
for 10 minutes at 121C in pressure cooker. After the unmasking step for BHV-1 the primary
antibody mouse anti-BHV 1 Clone F2 (VMRD), diluted 1:3000, was added and incubated for
30 minutes at room temperature (RT). Next the secondary antibody, biotinylated goat anti-
mouse (Vector Labs BA9200), diluted 1:200, was added and incubated for 30 minutes at RT.
The tertiary reagent (Label) horseradish peroxidase-labeled Streptavidin (Jackson Lab 016-
030-084), diluted 1:1000, was added and incubated for 30 minutes at RT. Finally the chromo-
gen AEC, RTU (Dako K3464), was added and incubated for 15 minutes at RT. The slides were
counterstained with Mayer’s hematoxylin and blued. Aqueous mounting medium was applied
and allowed to harden before permanent coverslips were mounted.
For BVDV staining the protocol was the same as for BHV-1 except the primary antibody
was mouse anti-BVDV (Idexx Clone 15.C.5), diluted 1:500.
Staining for BRSV was accomplished after epitope unmasking (see above for both BRSV
andMycoplasma bovis). The primary antibody, mouse anti-BRSV Clone 4–2 (Iowa State Uni-
versity), was diluted 1:100 and incubated for 30 minutes at RT. The secondary antibody (same
as BHV 1) was biotinylated goat anti-mouse (Vector Labs BA9200), diluted 1:200, and incu-
bated for 30 minutes at RT. The tertiary Reagent (Label): ABC (Vector PK6100) was incubated
for 30 minutes at RT and the chromogen and finishing was the same as for BHV 1.
IHC detection ofMycoplasma bovis used epitope unmasking as described for BRSV. The
primary antibody wasM. bovis rabbit polyclonal (CAHFS Bacteriology #1774 1/31/90) diluted
1:3000 and incubated for 30 minutes at RT. The secondary antibody was anti-rabbit horserad-
ish peroxidase labeled polymer (Dako K4003) incubated 30 minutes at RT. The tertiary reagent
(Label) was horseradish peroxidase-labeled streptavidin (Jackson Lab 016-030-084), diluted
1:1000, and incubated for 30 minutes at RT. Last the chromogen, AEC, RTU (Dako K3464),
was added and incubated for 15 minutes at RT. The slides were counterstained with Mayer’s
hematoxylin and blued. Aqueous mounting medium was applied and allowed to harden before
permanent coverslips were mounted.
Statistical Analysis
In the optimized study, composite scores were obtained on each of four animals for 10 conse-
cutive days (3 prior to challenge and 7 post challenge) for BRSV; 9 consecutive days (3 prior to
challenge and 6 post challenge) for IBR; 15 consecutive days post challenge for BVDV; 6 conse-
cutive days (2 prior to challenge and 5 post challenge) forM. haemolytica; 18 consecutive days
(3 prior to challenge and 15 post challenge) forM. bovis; and 8 consecutive days (2 prior to
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challenge and 6 post challenge) for P.multocida. Within each challenge level, four distinct ani-
mals were used as controls and composite scores were recorded on challenge and control ani-
mals at the same times. Missing values were present in the data leading to a total number of
observations (number of days observed × 4 animals—missing values) of 39, 35, 27, 60, 29, and
60 for challenged animals and 37, 35, 28, 70, 32 and 60 for matched controls for BRSV, IBR,
BVDV,M. haemolytica,M. bovis and P.multocida, respectively.
For each pathogen we fit the linear model:
yijkl¼ μþ TreatmentiþDayjþTreatment  Dayijþ Animalikþ eijkl
Where yijkl is a composite score, μ is the overall mean, Treatmenti (I = 1, 2) represents the
specific pathogen challenge or control, Dayj (j = 1, nj and nj are provided above for each treat-
ment) is the day within the consecutive sequence on which the composite score was observed,
Treatment × Dayij is the interaction term of interest in this study, Animalik is the effect of the
kth animal (k = 1, 4) within the ith treatment and eijkl is the residual which is assumed to be nor-
mally distributed with zero mean and constant variance. We performed an ANOVA to test the
significance of the Treatment × Dayij interaction and, when significant, tested the difference
between treatment levels (control vs. pathogen) within each day using a t-test and Bonferroni
correction to achieve an overall significance of P< 0.05 for each pathogen.
Results
Pilot Study: clinical signs and lung pathology
BRSV infected steers were necropsied on day 7 when clinical signs were determined to have
peaked. These included: fever, increased respiratory rate, cough, and adventitious lung sounds.
Lung pathology was consistent with expected lesions. as shown (Fig 1 and S1 Table). Immuno-
histochemistry on lung sections was positive for BRSV. Day 7 following challenge was deter-
mined to be an appropriate time point for necropsy and harvesting of tissues to be used for
RNA sequencing.
Infection with IBR virus induced clinical signs consisting of fever, nasal discharge, increased
respiratory rate and cough. In the pilot study, clinical scores were greatest on day 6 of infection
when necropsy was performed. Immunohistochemistry for IBR virus in the lung was positive
for one of the two steers. Day 6 was selected as the appropriate time to harvest tissues for RNA
sequencing in the optimized study. Pathology of the respiratory tract included erosions and
ulcerations in the trachea and laryngeal mucosa; lung consolidation and expected lung histopa-
thology (Fig 1 and S1 Table).
BVDV infection of the pilot study steers did not produce clinical signs of respiratory disease
that differed from pre-infection infection until necropsy on day 8. However, both steers had
diarrhea. At necropsy, one steer had 25% consolidation of the right apical lung lobe. Histopa-
thology showed some lymphocytic and neutrophilic accumulations in the lungs of both ani-
mals (Fig 1 and S1 Table). Both lungs were negative on immunohistopathology for BVDV.
However, gastrointestinal pathology revealed that there was depletion of Peyer’s Patch lympho-
cytes and there was positive immunohistochemical staining for BVDV in these tissues. These
pilot results suggested that a longer duration of infection would be desirable in the optimized
study to obtain more consistent clinical and pathological evidence of respiratory disease.
The clinical scores of the pilot study steers infected withMannheimia haemolytica did not
differ from those of the mock-infected control animals. Peak mean scores were highest between
days 3 and 5 following challenge and were not elevated on day 8 when necropsy was per-
formed. Some lung pathology was observed (S2 Table) butM. haemolytica was not isolated
from the lung of either pilot study animal. These data suggested that the optimized study
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Fig 1. Time course of the mean clinical scores for steers infected with viral pathogens andmock
infected controls. Infection with (A) BRSV occurred on day 0 and clinical sign scores are presented for the
next seven days. Mean (n = 4) scores were significantly different for both treatment versus day effect and for
treatment versus mock infected controls (p<0.005); Bonferroni post hoc test p<0.05. (B) IBR infection
occurred on day 0 and mean clinical sign scores are presented for the next six days. Mean (n = 4) scores
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should include infection with a more virulentM. haemolytica isolate and necropsy should be
performed on day 5 following challenge.
Infection of pilot study steers with Pasteurella multocida produced a slight peak in clinical
scores between days 2 and 4 and a decline to control levels by day 8 when necropsy was per-
formed. Clinical signs consisted of fever, nasal exudate, and occasional increased lung sounds
on auscultation. Only one of the two steers showed lung consolidation. Histopathological
observations are described in S2 Table. Pasteurella multocida was isolated from the lung of the
first steer but not from the steer that lacked lesions (S2 Table). These data suggested that a
more virulent isolate coupled with an earlier necropsy day (day 5) would be more effective for
induction of disease.
Mycoplasma bovis was the final challenge agent utilized in the pilot study. Despite culturing
M. bovis from the lungs and pharynx of both pilot study steers at necropsy on day 7, the clinical
signs for these animals did not differ from those of the control steers. No gross lesions were
observed in the lungs of one animal and the second animal had some lung consolidation (S2
Table); both animals had minimal histological changes. These results indicated that the dura-
tion of infection should be extended and a more virulentM. bovis isolate should be used to
induce a more severe disease prior to necropsy and tissue harvesting.
Lung pathology, gross and histopathology, is tabulated in detail for each calf in S1 Table
(viral pathogens) and S2 Table (bacterial pathogens).
Optimized Study: clinical signs
Infection with BRSV (n = 4) and mock infected controls (n = 4) was performed using the same
isolate and schedule as in the pilot study. The infected steers developed clinical signs beginning
on day 3, which peaked on day 7 (Fig 1A). Increased temperature, respiratory rate, cough, and
adventitious sounds on lung auscultation accounted for most of the score. The clinical signs
were significantly different from control (p<0.005, infection), the interaction and day effects
were also significant. Bonferroni post hoc test: p< 0.05 for days 6 and 7 post-infection.
Steers infected with IBR (n = 4) using the same isolate and infection schedule as in the pilot
study, showed a highly significant difference from mock infected controls (n = 4) beginning on
day 2 after infection (post-hoc Bonferroni test p< 0.05). Clinical scores stayed elevated
through day 6 when necropsy was performed (Fig 1B). These steers showed a significant
treatment × day effect.
Infection with BVDV (n = 4) and mock-infected controls (n = 4) was achieved using the
same isolate as used in the pilot experiment, but the duration of the experiment was extended
to necropsy on day 15. Maximum clinical scores were observed on days 7–9, with little differ-
ence from control animals apparent on days 10–15 (Fig 1C). Infection was significant
(p = 0.0013) as were day (0.0071), and treatment × day (P<0.027). Treated and control animals
differed only on day 8 following infection (Bonferroni post hoc test: p< 0.058).
Pasteurella multocida infections were performed using a different isolate (Table 2) from that
used in the pilot study and necropsy was performed earlier, on day 6. Antibody titers to P.mul-
tocida were evaluated by ELISA and found to be higher than desirable for experimental infec-
tion (personal communication A. Confer) on all steers available for the study. This precluded
were highly significantly different frommock infected controls; and treatment versus day effect was significant
(Bonferroni test p<0.05). (C) BVDV infection on day 0 was followed until day 15 and mean clinical scores are
presented for infected and mock infected controls. The effect of infection (p = 0.0013) and day (p = 0.0071)
were significant. Mean clinical sign scores were significantly different for infected and control steers only on
day 8 (Bonferroni p<0.058).
doi:10.1371/journal.pone.0142479.g001
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using seronegative steers. Despite the use of a new isolate, the difference in mean clinical score
between infected (n = 4) steers and mock infected control steers (n = 4) was not significant on
any day post infection.
Infection withMannheimnia haemolytica (n = 4) produced the highest clinical scores on
day 2 post-infection and the infected group continued to have elevated scores through nec-
ropsy on day 5 (Fig 2B). The difference between infected and mock infected steers (n = 4) was
significant (p = 0.00135), infection and day was significant (p = 0.0071) as was the difference
between treated and control animals from day 2 onward (Bonferroni post hoc test: p< 0.05).
The use of aMycoplasma bovis clinical isolate previously shown to induce experimental dis-
easeand the extension of the observation period was successful in producing infected animals
(n = 4) that had a clinical disease significantly different from mock infected control animals
(n = 4) beginning on day 3 and lasting through day 15 (Bonferroni post hoc test: p< 0.05) when
animals were euthanized for necropsy (Fig 2C). The effects of infection (p = 0.0054), day
(p<0.0028) and the interaction of treatment × day were also significant.
Bacterial isolations
Bacteria and mycoplasma isolated from lungs at necropsy and from deep pharyngeal swabs
before and during infection were tabulated in detail for each animal in S1 and S2 Tables, and
are summarized in Fig 3. Most BRSV infected steers had mixed flora in the posterior nasal cav-
ity at the start of the experiment; Pasteurella multocida was isolated from the nasal cavity of
both of the pilot study calves. Yet lungs from five of the six BRSV infected steers were negative
for bacteria and mycoplasma at necropsy.Mannheimnia haemolytica was present in the nasal
cavity in all six of the IBR infected steers by day 6 of infection; several steers had additional
organisms present. However, lungs from all six of these steers were negative for bacterial cul-
ture at necropsy. The lung swabs cultured for bacteria and mycoplasma in BVDV infected
steers were all negative despite the presence of a variety of bacteria and mycoplasma in the pos-
terior nasal cavity detected by swabs either pre-infection of during infection.
Mannheimia haemolytica was fairly consistently isolated from the posterior pharynx of the
M. haemolytica infected steers and from the lungs of all four of the optimized study steers.
Mycoplasma was consistently isolated from the posterior pharyngeal swabs and lungs ofM.
bovis infected steers in the optimized study.
Pathological Examination
Major histological lesions of lungs are reported in Fig 4 for each infection group and for indi-
vidual animals in S1 Table (viral pathogens) and in Fig 5 and S2 Table (bacterial pathogens).
Representative gross lung lesions are presented in Fig 6 for viral pathogens and in Fig 7 for bac-
terial pathogens. For those pathogens that induced characteristic pathological lesions in the
pilot study steers, tissue samples were retained for RNA extraction, thereby increasing the ani-
mal sample number for these pathogens to six.
In the six BRSV infected steers, the lung consolidation varied from an overall 10% to 40%,
with differences in individual lobe consolidation within and between steers. As shown in Figs
4A and 6A all BRSV infected steers had consolidation. Atelectasis was present in some lung
lobes and generalized emphysema was apparent in one steer. The frequency of the most char-
acteristic histological lesions is also documented in Fig 4A. Histological examination showed
neutrophilic or pleocellular proliferative necrotizing bronchitis and bronchiolitis in all (6 out
of 6) infected steers. Immunohistochemistry for BRSV was positive in all 6 lungs. There were
syncytial cells and neutrophilic alveolitis noted in 2 of the 6 steers bacteria were culture from
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Fig 2. Time course of the mean clinical scores for infected steers infected with bacterial pathogens
andmock infected controls. Infection with (A) Pasteurella multocida on day 0 was followed until day 6. At
no time was the difference in mean clinical scores significantly different between infected (n = 4) and mock
infected control steers (n = 4). (B) Day 0 infection withMannheimnia haemolytica was followed for five days.
Mean clinical scores were significantly different from day 2 through day five between infected (n = 4) and
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PLOSONE | DOI:10.1371/journal.pone.0142479 November 16, 2015 12 / 23
the lungs of only one of the six steers. Examples of characteristic BRSV histological lesions are
shown in Fig 8A. Immunohistochemical staining for BRSV is shown in Fig 8B.
Lungs from six infectious bovine rhinotracheitis virus infected steers showed 5% to 15%
overall lung consolidation (Fig 6B); with disseminated atelectasis and necrosis present in lungs
from two of the six steers Ulcerative rhinitis, laryngitis (6 out of 6), and tracheitis (4 out of 6)
were present in (Fig 4B) and shown in Fig 6C. On microscopic examination, there were ulcers
and erosion with neutrophilic infiltrates in the larynx and trachea; nuclear inclusions were
demonstrated in two of six steers Lung histology showed lymphoplasmocytic bronchitis, bron-
chiolitis, alveolitis, and some disseminated bronchopneumonia (Figs 4B and 9A). Five of the
six IBR infected lungs were stained positive for IBR virus with immunohistochemistry (Fig 9B).
Consolidation varied from 0% overall to 25% in the six BVDV infected steers. Overall gross
pathology was minimal. Histological examination showed diffuse lymphocytic and neutro-
philic infiltrates in tracheal mucosa and surrounding bronchi in the lung; atelectasis was com-
mon and focal bronchopneumonia was present in some. Individual differences in lung
histology accompanied the presence ofMycoplasma bovis in the lungs of three steers detailed
in S1 Table. In the ileum, Peyer’s patches showed characteristic lymphoid depletion (Fig 10A)
and positive staining by immunohistochemistry for BVDV (Fig 10B).
Gross and histological findings from bacterial pathogens are described in Figs 5, 11 and 12.
Lung consolidation varied from 0 to 30%, with some lungs showing primarily atelectasis (Fig
8A and 8B).Mannheimia haemolytica was isolated from all four of theMannheimnia haemoly-
tica infected steers in the optimized study and from none of those in the pilot study. The lung
control steers (p = 0.00135); and the effect of infection and treatment was significant (p = 0.0071), Bonferroni
test p<0.05. (C) Infection withMycoplasma bovis on day 0 was followed through day 15 and the difference in
mean clinical scores was significant from day 3 through day 15 (Bonferroni p, 0.05). The effect of infection
(p = 0.0054) and day (p = 0.0028) was significant.
doi:10.1371/journal.pone.0142479.g002
Fig 3. Bacterial isolations from pharyngeal swabs. To evaluate the presence of the BRDC bacterial pathogens in the posterior pharynx of steers before
and after infection, sheathed swabs were taken at intervals and at necropsy. The number of steers from each pathogen infection group (x axis) that had each
of the bacterial pathogens isolated from the upper respiratory tract either during infection or at necropsy is shown (y axis).
doi:10.1371/journal.pone.0142479.g003
Single Pathogen Challenge with Agents of the BRDC
PLOSONE | DOI:10.1371/journal.pone.0142479 November 16, 2015 13 / 23
Fig 4. The number of virus infected steers with specific pathological lesions-combined pilot and
optimized studies (A-K on x axis) is shown for steers infected with: (A) BRSV, (B) IBR, and (C) BVDV.
Lesions are: A) total lung consolidation >1%, B) neutrophilic proliferative necrotizing bronchiolitis/bronchitis,
C) supperative bronchopneumonia, D) syncytial formation, E) neutrophilic alveolitis, F) plasmacytic
bronchitis/bronchiolitis, G) bacterial culture positive, H) ulcerative rhinitis, I) laryngeal ulceration or erosion, J)
tracheal ulceration, K) intranuclear inclusion bodies.
doi:10.1371/journal.pone.0142479.g004
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histology from those four steers showed subacute necrotizing fibrinocellular lobar pneumonia
with coagulation necrosis and pleuritis and is described for each animal in Fig 11 and S2 Table.
Pasteurella multocida produced minimal gross lung pathology (Fig 7C). However, histopa-
thology of the pilot study steers showed multiple lesions, including chronic bronchopneumonia
and alveolitis (Fig 5). All four of the optimized study steers hadMycoplasma bovis isolated
from their lungs at necropsy, making this an inadvertent mixed pathogen infection. Histologi-
cal lesions of bronchiolitis (lymphoid-lymphofollicular) could be attributed to theM. bovis.
Lungs from twoMycoplasma bovis infected steers from the pilot study were examined and
found to have no gross lesions. Three steers from the optimized study were examined. The
fourth steer was euthanized early due to extreme disease and was eliminated from the study
Fig 5. The number of bacterial infected steers with specific pathological lesions (A-F)-combined pilot
and optimized studies. + on x axis) is shown for steers infected with: (A)Mannheimnia haemolytica, (B)
Pasteurella multocida, and (C)Mycoplasma bovis. Lesions are: A) total lung consolidation <1%, B)
neutrophilic bronchitis/bronchiolitis, C) subacute necrotizing fibrinocellular lobar pneumonia and pleuritis, D)
neutrophilic bronchopneumonia with necrosupperative obliterating bronchiolitis/bronchitis, E) lymphocytic
bronchitis/bronchiolitis, F) lymphoid hyperplasia.
doi:10.1371/journal.pone.0142479.g005
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(M. haemolytica was diagnosed as the causal agent at necropsy). Consolidation varied from 3%
to 35% in the remaining steers.M. bovis was cultured from all three (Figs 5C and 12A and S2
Table). Necrosuppurative obliterating bronchiolitis and lymphoid hyperplasia were consistent
findings. Immunohistochemistry for Mycoplasma bovis was positive and is shown in Fig 12B.
Examination of lungs from bacterial and viral control calves showed no gross lesions and
there was no bacterial growth from the lungs at necropsy. Mild bronchus associated lymphoid
tissue (BALT) hyperplasia was present on microscopic examination of lungs from the viral
control steers (58, 101) and one bacterial control steer (102).
Discussion
Bovine respiratory disease complex is not a single disease; it is a syndrome caused by the inter-
action of several viral and bacterial infections that together cause clinical disease and lung
pathology. Each pathogen is unique in its interaction with the immune system of the bovine
host and the particular immune responses that are most protective for each are not necessarily
identical. For many years, the approach to prevention of BRDC has been the development of
vaccines for the various component pathogens and altering modes of cattle processing and
shipping to decrease stress. The use of prophylactic antibiotic therapy is also common in many
conditioning programs. Current regulatory efforts to decrease the usage of antibiotics in live-
stock emphasize the need to find alternate means of controlling BRDC. The tools for analysis
of gene expression and the identification of heritable resistance traits are now available and
make it possible to evaluate gene expression in response to environmental stimuli, such as
infection with a particular pathogen. The work described herein was performed to provide tis-
sues from single pathogen challenge for each of the most important BRDC pathogens for the
Fig 6. Examples of gross pulmonary pathology from virus infected steers: (A) BRSV infected lung
showing lobar lung consolidation (dark areas), (B) IBR infected lung with consolidation (arrow) and scattered
areas of atelectasis and necrosis, (C) IBR infected larynx showing areas of ulceration and erosion (arrow),
and (D) BVDV lung showing minimal pathology with scattered small areas of consolidation (arrow).
doi:10.1371/journal.pone.0142479.g006
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purpose of RNA sequencing. Identification of genes involved in the response to each pathogen
provides the framework for the recognition of gene variants in larger populations that can
serve as potential candidates for selective breeding of cattle more resistant to the agents of
BRDC. Ongoing work by our group focuses on evaluation of the genes differentially expressed
in each of these single pathogen infections. Initial studies on immunological responses using
RNA sequence analysis of bronchial lymph nodes of these animals is presented [3].
Each single pathogen infection had a unique time course for the disease process in each of
the six pathogens. Infections with the viral pathogens BRSV, IBR and BVDV each showed a
different time course. Necropsy of steers on day 7 of BRSV infection showed typical lesions
and the presence of virus in the lung. In contrast BVDV took 15 days to show maximum clini-
cal disease and the presence of virus in the ileum. Experimental infection withM. haemolytica
caused clinical signs to appear on day 2. In the BRDC, the viral infection usually precedes the
bacterial infection of the lung making it difficult to identify the initiation of the bacterial infec-
tion. These observations underscore the need for single infection data to assure optimum tissue
sampling for gene expression studies and for understanding the pathogenesis of each unique
host/pathogen interaction.
The interaction of pre-existing pharyngeal flora with experimental infection showed that
existence of low numbers of other bacterial organisms, in the upper respiratory tract, is not
likely to alter gene expression data obtained from lung or lung associated lymph nodes of
experimentally infected steers. Culture of the posterior pharyngeal flora was performed with
sheathed swabs. The data is presented in Fig 3 and S3 Table. Culture of the posterior pharynx
of the six BRSV infected steers prior to infection with BRSV showed that only one animal was
Fig 7. Examples of gross pathology from bacterial infected steers: (A)Mannheimnia haemolytica lung
showing consolidation (arrow) and (B) Lung fromMannheimia haemolytica infected steer demonstrating
irregular dark red consolidated regions bordered by light grey inflammatory infiltrate with expanded
interlobular septa. (C) Pasteurella multocida infected lung with minimal lesions consisting of scattered areas
of consolidation (arrows), and (D) Lung fromMycoplasma bovis infected steer demonstrating a focal region
(lower left) of consolidation associated with bronchitis with luminal exudate.
doi:10.1371/journal.pone.0142479.g007
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negative for bacteria and mycoplasma. Despite the presence of bacteria in the pharynx at the
time of infection in five steers, bacteria were isolated from the lung of only one steer at nec-
ropsy. This isolate was described as rare (few organisms found) and it was the same genus and
species (P.multocida) that was isolated from the pharynx prior to infection. The same trend
was apparent for IBR:M. haemolytica was present in the pharynx on either day 0 or day 6 in all
six steers, yet the lung was negative at necropsy for these bacteria in all IBR infected steers.
BVDV infected steers show a different pattern: four out of six steers had mycoplasma present
in the pharyngeal region prior to infection and three of those four hadM. bovis cultured from
the lung at necropsy. Bacteria were present on day 0 in the pharynx of four of the six steers
(these included P.multocida andM. haemolytica); yet none of these were cultured from the
lung at necropsy.
Necropsy observations for all three viral pathogens,M. haemolytica, andM. bovis included
classic lesions, as previously described for these agents [8,9,10,11,12,13]. BRSV lesions were
classic, as we have shown previously with this isolate. These included multilobular
Fig 8. Histopathology of lung from BRSV infected steer. (A) Bronchiolitis with epithelial necrosis and
numerous syncytia (arrows), (B) Immunohistochemistry stain showing positive stain for BRSV in bronchioles
(brown color and arrow).
doi:10.1371/journal.pone.0142479.g008
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consolidation with histiological lesions of bronchiolitis with epithelial necrosis and syncytia
[14]. For infectious bovine rhinotracheitis we saw the expected nasal, laryngeal, and tracheal
mucosal erosion and ulceration. Lung involvement in steers that were negative for bacteria
showed lymphocytic/plasmocytic pneumonia and pleocellular bronchitis accompanied by the
identification of inclusion bodies which was clearly representative of field cases of IBR. Finally
the classic BVDV lesions in Peyer’s Patches, the presence of lymphoid depletion, indicates that
the BVDV infection targeted the expected cells and confirmed that the infection was produc-
tive and representative of field cases.
The main lesions noted inM. haemolytica infected steers were fibrinosuppurative or fibri-
nocellular pneumonia with or without pleuritis. Histological lesions included coagulation
necrosis and fibrinocellular exudation. Bronchiolitis obliterans or chronic obliterating bronchi-
tis were commnly associated with P.multocida infection in spite of the lack of significant clini-
cal signs. In those cases from whichM. bovis was isolated from the lung lymphofollicular
bronchitis and bronchiolitis were common findings. Peribronchial lymphoid hyperplasia with
Fig 9. Histopathology of pharynx from IBR infected steer. (A) Focal ulcerative pharyngitis with epithelial
necrosis (area indicated by length of the arrow), (B) Immunohistochemistry of lesions demonstrating positive
cytoplasmic staining for IBR, indicated by arrows and red/brown color.
doi:10.1371/journal.pone.0142479.g009
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a mixed leukocyte infiltrate was the singular most predominant lesion associated withM. bovis
infection. As shown in S2 Table, each steer had a variety of pathological abnormalities and the
presence of neutrophil accumulations in interstitial tissues and in airways was a common find-
ing. It is neither unexpected nor novel to have observed this pathology; in fact it is assuring to
know that the experimental infections mimicked to a large degree natural disease findings.
As recognized in the field BRDC is a multi- pathogen disease with host- pathogen and path-
ogen-pathogen interactions intensified by environmental factors that create stress. Thus, for
the bacterial infections in the absence of viral infection and with none of the usual stress fac-
tors, the nature of the disease was not as severe as generally occurs when the pathogen is com-
bined with the other inciting factors in BRDC. To accomplish the goal of understanding which
genes are activated in response to each pathogen alone, it was necessary to perform single path-
ogen challenge and this goal was achieved for six of the seven major BRDC pathogens.
Fig 10. Histopathology of the ileum from a BVDV infected steer. (A) shows section of ileum with depletion
of lymphocytes from Peyer’s patches (arrows), and (B) Immunohistochemistry showing positive staining for
BVDV in ileum of infected steer (arrow showing brown color).
doi:10.1371/journal.pone.0142479.g010
Fig 11. Histopathology of the lung from aMannheimnnia haemoytica infected steer. Lobar pneumonia
with irregular multilobular zones of coagulation necrosis and fibrinocelluar exudation bordered by dense
bands of necrotic leukocytes (arrows).
doi:10.1371/journal.pone.0142479.g011
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Summary and Conclusions
Experimental infection of bovine steers was successfully performed with each of three viral,
two bacterial, and one mycoplasmal agents of BRDC after optimizing conditions for infection.
For five of the six pathogens clinical sign scores were significantly different from those of
mock-infected control steers. Lung pathology was consistent with expected lesions for each of
those pathogens. Herein we have presented optimized protocols for induction of disease by
each of the major BRDC pathogens in the absence of confounding conditions or infections. In
the P.multocida steers, who failed to show a significant difference from control steers, the pres-
ence of high antibody titers prior to infection was a potential protective factor and serves to
illustrate the benefit of humoral immunity against this pathogen.
Fig 12. Histopathology of the lung fromMycoplasma bovis infected steer. (A) necrosuppuratve
bronchiolitis with peribronchiolar mixed leukocytic infiltrate (arrow), (B) Immunohistochemistry of lesion
demonstrating positive staining forMycoplasma bovis in the bronchiolar luminal exudate (brown color and
arrow).
doi:10.1371/journal.pone.0142479.g012
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